Search

Your search keyword '"Prokopowicz, M."' showing total 154 results

Search Constraints

Start Over You searched for: Author "Prokopowicz, M." Remove constraint Author: "Prokopowicz, M."
154 results on '"Prokopowicz, M."'

Search Results

1. Carbon Nanomaterials Application as a Counter Electrode for Dye-Sensitized Solar Cells

2. Nanocrystalline TiO2 Powder Prepared by Sol-Gel Method for Dye-Sensitized Solar Cells

3. Carbon Nanotubes Counter Electrode for Dye-Sensitized Solar Cells Application

10. P981Lvot area measurement using gated ct data reclassifies aortic stenosis severity as graded by echocardiographyP982Paradoxical low-flow low-gradient aortic stenosis: an intermediate state between moderate and severe aortic stenosis?P983Can rheumatic significant mitral stenosis be a cause of paradoxical low gradient, low flow, in patients with severe aortic stenosis? an echocardiographic and outcome studyP984Clinical and hemodynamic comparison of isolated versus combined aortic and mitral stenosisP985Echocardiographic end-diastolic velocity in the proximal descending aorta should be interpreted with caution when the ascending aorta is dilated: insights from cardiovascular magnetic resonanceP987Prevalence of atrial mitral regurgitation in patients with severe mitral regurgitationP988Role of 2D/3D echocardiography in the risk stratification of endocardial lead-related tricuspid regurgitation: a single-centre study among?241 patientsP989When TEE is needed in patients with staphylococcus aureus bacteremia for the assessment of risk profile of infective endocarditis?P990Appropriateness criteria to echocardiograms for suspected infective endocarditis: experience of a tertiary referral centerP991Independent predictors of outcome in infective endocarditisP992The role of transesophageal cardiography in clinical course and prognosis of complicated infective endocarditis in critically ill patients: our 15 years experienceP993Left bundle branch block atypical pattern as a prognostic determinant in patients taken to TAVIP994Efficacy of long-term ivabradine therapy in severe systolic chronic heart failure patients with and without type 2 diabetes mellitusP995Relations between left ventricular reverse remodeling and serum markers of extracellular matrix fibrosis in dilated cardiomyopathyP996The healthy left ventricle accommodates an increasing vortex formation time for volume transfer in diastolic filling :Implications for heart failureP997Evolutionary changes of pulmonary artery pressure after left ventricular assist device implantP998Functional correlates and prognostic value of coronary flow velocity reserve by vasodilator stress echocardiography in hypertrophic cardiomyopathyP999Quantification of myocardial performance in patients with non-obstructive versus latent-obstructive hypertrophic cardiomyopathyP1000Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessmentP1001Impact of fibrosis visualized by CMR in vectorcardiogram recordings of patients with suspected arrhythmogenic cardiomyopathyP1002Determinants of the beneficial effect of aldosterone antagonism on exercise capacity in heart failure with reduced ejection fractionP1003Myocardial strain values in patients with acute myocarditis and preserved ejection fraction. A magnetic resonance feature tracking studyP1004Detection of subclinical left ventricular dysfunction by speckle tracking echocardiography in patients with myocarditis without prominent wall motion abnormalitiesP1005Aborted sudden cardiac death patients aged <50 years show only mild alterations on cardiac magnetic resonance imagingP1006Relationships between subepicardial and subendocardial longitudinal strain with late gadolinium enhancement in uncomplicated hypertensive patients

14. Nanocrystalline TiO2 Powder Prepared by Sol-Gel Method for Dye-Sensitized Solar Cells.

15. Abstracts

17. AQM-MD simulation approach to the analysis of FRET processes in (bio)molecular systems. A case study: complexes of E. coli purine nucleoside phosphorylase and its mutants with formycin A.

23. In Vitro Measurement of Conformational Stability of Fibrinogen Adsorbed on Siloxane

31. 14. Ventricular Fibrillation & Out-of-Hospital Cardiac Arrest.

32. A new approach to generation of standard gas mixtures used in the calibration of gas analyzers

33. Evaluation of the Safety and Potential Benefits of Beetroot-Based Dietary Supplements According to Their Elemental Composition.

34. An unusual long-term follow-up of a patient with a left ventricular pseudoaneurysm after myocardial infarction.

35. Biocompatible antibiotic-loaded mesoporous silica/bioglass/collagen-based scaffolds as bone drug delivery systems.

36. Antioxidant Capacity, Nitrite and Nitrate Content in Beetroot-Based Dietary Supplements.

37. Bioglass obtained via one-pot synthesis as osseointegrative drug delivery system.

38. Cardiovascular, Pulmonary, and Neuropsychiatric Short- and Long-Term Complications of COVID-19.

39. Assessment of the Mineral Composition and the Selected Physicochemical Parameters of Dietary Supplements Containing Green Tea Extracts.

40. Antioxidant-Loaded Mesoporous Silica-An Evaluation of the Physicochemical Properties.

41. Mineral Composition of Dietary Supplements-Analytical and Chemometric Approach.

42. Evaluation of Physicochemical Properties of Beetroot-Based Dietary Supplements.

43. Molecular Mechanism of Thymidylate Synthase Inhibition by N 4 -Hydroxy-dCMP in View of Spectrophotometric and Crystallographic Studies.

44. Mesoporous Silica-Bioglass Composite Pellets as Bone Drug Delivery System with Mineralization Potential.

45. Advanced Spectroscopy and APBS Modeling for Determination of the Role of His190 and Trp103 in Mouse Thymidylate Synthase Interaction with Selected dUMP Analogues.

46. The Links between Cardiovascular Diseases and Alzheimer's Disease.

47. Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.

48. Microwave-Assisted Fabrication of Mesoporous Silica-Calcium Phosphate Composites for Dental Application.

49. Response to antiplatelet therapy in patients undergoing invasive treatment due to acute coronary syndrome complicated by cardiogenic shock.

50. Mesoporous silica pellets as bifunctional bone drug delivery system for cefazolin.

Catalog

Books, media, physical & digital resources